These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Lipases and HDL metabolism. Jin W; Marchadier D; Rader DJ Trends Endocrinol Metab; 2002; 13(4):174-8. PubMed ID: 11943562 [TBL] [Abstract][Full Text] [Related]
4. Is reverse cholesterol transport a misnomer for suggesting its role in the prevention of atheroma formation? Quintão EC Atherosclerosis; 1995 Jul; 116(1):1-14. PubMed ID: 7488324 [TBL] [Abstract][Full Text] [Related]
5. Remodelling of high density lipoproteins by plasma factors. Rye KA; Clay MA; Barter PJ Atherosclerosis; 1999 Aug; 145(2):227-38. PubMed ID: 10488948 [TBL] [Abstract][Full Text] [Related]
6. Molecular mechanism of reverse cholesterol transport: reaction of pre-beta-migrating high-density lipoprotein with plasma lecithin/cholesterol acyltransferase. Nakamura Y; Kotite L; Gan Y; Spencer TA; Fielding CJ; Fielding PE Biochemistry; 2004 Nov; 43(46):14811-20. PubMed ID: 15544352 [TBL] [Abstract][Full Text] [Related]
7. Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease. Quaschning T; Krane V; Metzger T; Wanner C Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S14-9. PubMed ID: 11576915 [TBL] [Abstract][Full Text] [Related]
8. Hydrolysis of phosphatidylcholine by hepatic lipase in discoidal and spheroidal recombinant high-density lipoprotein. Tansey JT; Thuren TY; Jerome WG; Hantgan RR; Grant K; Waite M Biochemistry; 1997 Oct; 36(40):12227-34. PubMed ID: 9315860 [TBL] [Abstract][Full Text] [Related]
9. Metabolic and genetic control of HDL cholesterol levels. Tall AR J Intern Med; 1992 Jun; 231(6):661-8. PubMed ID: 1619389 [TBL] [Abstract][Full Text] [Related]
10. HDL: the metabolism, function, and therapeutic importance. Wang M; Briggs MR Chem Rev; 2004 Jan; 104(1):119-37. PubMed ID: 14719972 [No Abstract] [Full Text] [Related]
11. In vitro formation of HDL-2 from HDL-3 and triacylglycerol-rich lipoproteins by the action of lecithin:cholesterol acyltransferase and cholesterol ester transfer protein. Zechner R; Dieplinger H; Steyrer E; Groener J; Calvert D; Kostner GM Biochim Biophys Acta; 1987 Mar; 918(1):27-35. PubMed ID: 3828365 [TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein A-IFIN (Leu159-->Arg) mutation affects lecithin cholesterol acyltransferase activation and subclass distribution of HDL but not cholesterol efflux from fibroblasts. Miettinen HE; Jauhiainen M; Gylling H; Ehnholm S; Palomäki A; Miettinen TA; Kontula K Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3021-32. PubMed ID: 9409289 [TBL] [Abstract][Full Text] [Related]
13. Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. Tall AR J Clin Invest; 1990 Aug; 86(2):379-84. PubMed ID: 2200802 [No Abstract] [Full Text] [Related]
14. The role of HDL and its modulators in the development of diabetes. Ng DS; Saw NM Curr Opin Lipidol; 2012 Apr; 23(2):167-8. PubMed ID: 22418575 [No Abstract] [Full Text] [Related]
15. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT. Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726 [TBL] [Abstract][Full Text] [Related]
16. The anatomy and physiology of reverse cholesterol transport. Reichl D; Miller NE Clin Sci (Lond); 1986 Mar; 70(3):221-31. PubMed ID: 3004796 [No Abstract] [Full Text] [Related]